Bemiparin

Phase 3Small molecule

RRovi Pharmaceuticals Laboratories

Bemiparin is one of 128 small molecule programs targeting Venous Thromboembolism. It is currently in Phase 3.

Indications

Total Trials

Active Trials

127

Competitors

Pipeline

Status by Indication[3][1]

Indication

Venous ThromboembolismActive, not recruiting

Small Cell Lung CarcinomaActive, not recruiting

COVID-19Active, not recruiting

Diabetic FootActive, not recruiting

Renal InsufficiencyActive, not recruiting

Venous ThromboembolismPreclinical

Active, not recruiting

Small Cell Lung CarcinomaPhase 2

Active, not recruiting

COVID-19Phase 2

Active, not recruiting

Diabetic FootPhase 3

Active, not recruiting

Renal InsufficiencyPhase 1

Active, not recruiting

Competition

Competitive Landscape

1931 competitors in COVID-19

#DrugCompanyPhaseTrials

Bemiparin

RRovi Pharmaceuticals Laboratories

Phase 3

1 2

Spikevax

Moderna

Preclinical

21 3

Calcium

Eli Lilly

Preclinical

—4

Selenium

SSWOG Cancer Research Network

Preclinical

1 5

Other Tkis

Bayer

Preclinical

1 6

Mrna-1273.211

Moderna

Preclinical

1 7

SARS-Cov-2 Bivalent MRNA Vaccine

AAIM Vaccine Co., Ltd.

Preclinical

2 8

AZD 1222

UUniversity Medicine Greifswald

Preclinical

2 9

Administration of Almitrine

CCentre Hospitalier Universitaire de Nice

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

N/ARecruiting

Prophylaxis

NCT05569681

Clinical

Trials by Indication[1]

Prophylaxis3 trials

Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries

Completed·HHawler Medical University·N/A·NCT01630148·774 enrolled

Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)

Terminated·—·Phase 3·NCT00311896·402 enrolled

Two Different Regimens of Bemiparin as a Thromboprophylaxis in Morbidly Obese Surgical Patients

Recruiting·HHawler Medical University·N/A·NCT05569681·2,400 enrolled

Low Molecular Weight Heparin2 trials

Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum

Completed·HHawler Medical University·N/A·NCT01588171·7,020 enrolled

Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths

Completed·HHawler Medical University·Phase 1·NCT03601338·140 enrolled

COVID-191 trial

Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19

Terminated·FFundación de investigación HM·Phase 2·NCT04420299·81 enrolled

Safety and Efficacy1 trial

Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients

Unknown status·IInstituto de Investigación Marqués de Valdecilla·Phase 3·NCT02802605·225 enrolled

Renal insufficiency1 trial

Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly

Completed·RRovi Pharmaceuticals Laboratories·Phase 1·NCT00413088·60 enrolled

6 more indications

Surgery1 trial

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Completed·RRovi Pharmaceuticals Laboratories·Phase 3·NCT00219973·526 enrolled

Diabetic Foot1 trial

Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers

Completed·RRovi Pharmaceuticals Laboratories·Phase 3·NCT00448903·329 enrolled

Treatment1 trial

Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients

Terminated·SSpanish National Health System·Phase 2/3·NCT00399425·84 enrolled

Oral1 trial

Pharmacokinetic Study of Two Oral Bemiparin Formulations

Completed·RRovi Pharmaceuticals Laboratories·Phase 1·NCT00863577·102 enrolled

Small Cell Lung Carcinoma1 trial

Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)

Terminated·—·Phase 2·NCT00324558·39 enrolled

Venous Thromboembolism1 trial

Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients

Completed·MMohamed Sayed Mohamed Abbas·N/A·NCT02795065·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 14 trial records for Bemiparin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bemiparin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bemiparin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Rovi Pharmaceuticals Laboratories company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: RRovi Pharmaceuticals Laboratories

Bemiparin

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Prophylaxis3 trials

Low Molecular Weight Heparin2 trials

COVID-191 trial

Safety and Efficacy1 trial

Renal insufficiency1 trial

Surgery1 trial

Diabetic Foot1 trial

Treatment1 trial

Oral1 trial

Small Cell Lung Carcinoma1 trial

Venous Thromboembolism1 trial

References

Drug Info

Quick Facts

Related News